PAREXEL Simplifies Access to Knowledge

June 20, 2018
A new report by the Economist Intelligence Unit (EIU) and commissioned by PAREXEL International Corporation reveals that new innovations in drug development have a positive impact on clinical trial timelines, likelihood of market launch, and inclusion on selected payer formularies.
Previous Video
Salesforce Optimization Video - User Perspective [Jim Anthony]
Salesforce Optimization Video - User Perspective [Jim Anthony]

Next Video
PAREXEL's Patient Innovation Center
PAREXEL's Patient Innovation Center

Learn how PAREXEL’s Patient Innovation Center simplifies the patient journey through clinical development t...